HomepageMedicinePharma Pulse 5/17/24: AI & ML Through the Eyes of the FDA, Johnson & Johnson to Acquire Proteologix & more Medicine Pharma Pulse 5/17/24: AI & ML Through the Eyes of the FDA, Johnson & Johnson to Acquire Proteologix & more admin Posted on May 20, 2024 The latest news for pharma industry insiders. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostDLF rental arm DCCDL’s office rental income rises 7% in FY24 Next PostIs There an Alternative to the Little Black Dress? You Might Also Like Medicine FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder admin April 4, 2024 Medicine Viralgen and Axovia Partner to Manufacture Gene Therapy for Retinal Dystrophy in Bardet-Biedl Syndrome Patients admin January 27, 2025 Medicine Merck, Johnson & Johnson Announce Acquisitions to Bolster Respective Oncology Pipelines admin January 10, 2024 Medicine From Numbers to Negotiations admin February 12, 2024
Medicine FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder admin April 4, 2024
Medicine Viralgen and Axovia Partner to Manufacture Gene Therapy for Retinal Dystrophy in Bardet-Biedl Syndrome Patients admin January 27, 2025
Medicine Merck, Johnson & Johnson Announce Acquisitions to Bolster Respective Oncology Pipelines admin January 10, 2024